Advanced search
Publication Cover
Hematology Volume 29, 2024 - Issue 1
Submit an article Journal homepage
187
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A retrospective study of prognostic factors and treatment outcome in advanced-stage Mycosis Fungoides and Sezary Syndrome

Zhuo-fan Xua Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of China;c School of Medicine, Tsinghua University, Beijing, People’s Republic of ChinaView further author information
,
Hongyun Chena Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of ChinaView further author information
,
Yuehua Liub Department of Dermatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of ChinaView further author information
,
Wei Zhanga Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9489-5965View further author information
ORCID Icon,
Hongzhong Jinb Department of Dermatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Jie Liub Department of Dermatology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Article: 2366631 | Received 13 Jan 2024, Accepted 30 May 2024, Published online: 08 Jul 2024

References

  • Bradford, P.T., et al., Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood, 2009. 113(21): p. 5064-5073. DOI:10.1182/blood-2008-10-184168
  • Mehta-Shah, N., et al., Nccn guidelines insights: primary cutaneous lymphomas, version 2.2020. J Natl Compr Canc Netw, 2020. 18(5): p. 522-536. DOI:10.6004/jnccn.2020.0022
  • Hristov, A.C., T. Tejasvi, and R.A. Wilcox, Mycosis fungoides and Sezary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol, 2019. 94(9): p. 1027-1041. DOI:10.1002/ajh.25577
  • Diamandidou, E., et al., Prognostic factor analysis in mycosis fungoides/Sezary syndrome. J Am Acad Dermatol, 1999. 40(6 Pt 1): p. 914-924. DOI:10.1016/S0190-9622(99)70079-4
  • Kim, Y.H., et al., Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Arch Dermatol, 2003. 139(7): p. 857-866.
  • Ku, L.S. and K.K. Lo, Mycosis fungoides – a retrospective study of 40 cases in Hong Kong. Int J Dermatol, 2005. 44(3): p. 215-220. DOI:10.1111/j.1365-4632.2004.02362.x
  • Suzuki, S.Y., et al., Prognosis of 100 Japanese patients with mycosis fungoides and Sezary syndrome. J Dermatol Sci, 2010. 57(1): p. 37-43. DOI:10.1016/j.jdermsci.2009.10.010
  • Benner, M.F., et al., Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood, 2012. 119(7): p. 1643-1649. DOI:10.1182/blood-2011-08-376319
  • Scarisbrick, J.J., et al., Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis Fungoides and Sezary syndrome: effect of specific prognostic markers on survival and development of a prognostic model. J Clin Oncol, 2015. 33(32): p. 3766-3773. DOI:10.1200/JCO.2015.61.7142
  • Talpur, R., et al., Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009. Clin Cancer Res, 2012. 18(18): p. 5051-5060. DOI:10.1158/1078-0432.CCR-12-0604
  • Hanel, W., et al., A retrospective comparative outcome analysis following systemic therapy in mycosis fungoides and Sezary syndrome. Am J Hematol, 2016. 91(12): p. E491-E495.
  • Hughes, C.F., et al., Lack of durable disease control with chemotherapy for mycosis fungoides and Sezary syndrome: a comparative study of systemic therapy. Blood, 2015. 125(1): p. 71-81. DOI:10.1182/blood-2014-07-588236
  • Olsen, E.A., et al., Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol, 2011. 29(18): p. 2598-2607. DOI:10.1200/JCO.2010.32.0630
  • Quaglino, P., et al., Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium. Ann Oncol, 2017. 28(10): p. 2517-2525. DOI:10.1093/annonc/mdx352
  • Han, J.H., et al., Characteristics of cutaneous lymphomas in Korea according to the New WHO-EORTC classification: report of a nationwide study. Korean J Pathol, 2014. 48(2): p. 126-132. DOI:10.4132/KoreanJPathol.2014.48.2.126
  • Fujii, K., et al., Cutaneous lymphoma in Japan, 2012-2017: a nationwide study. J Dermatol Sci, 2020. 97(3): p. 187-193.
  • Jung, J.M., et al., Mycosis fungoides in children and adolescents: a systematic review. JAMA Dermatol, 2021. 157(4): p. 431-438. DOI:10.1001/jamadermatol.2021.0083
  • Welfringer-Morin, A., et al., Clinical features, histological characteristics, and disease outcomes of mycosis fungoides in children and adolescents: a nationwide multicentre cohort of 46 patients. Dermatology, 2023. 239(1): p. 132-139. DOI:10.1159/000526788
  • Olsen, E.A., et al., Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood, 2022. 140(5): p. 419-437. DOI:10.1182/blood.2021012057
  • Elsayad, K., et al., Low-dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T-cell lymphoma. J Dtsch Dermatol Ges, 2022. 20(3): p. 279-285.
  • Stadler, R., et al., O-143 - RESMAIN: results of a multicenter, randomized, double blind, placebocontrolled trial to evaluate resminostat for maintenance treatment in advanced stage mycosis fungoides or Sézary syndrome. Eur J Cancer, 2023. 190: p. 113031. DOI:10.1016/j.ejca.2023.113031

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.